CVS Health Co. (NYSE:CVS) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 2.7% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,445,116 shares of the pharmacy operator’s stock after selling 264,368 shares during the period. Dimensional Fund Advisors LP owned 0.75% of CVS Health worth $557,776,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the company. Wedmont Private Capital raised its holdings in shares of CVS Health by 0.8% in the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after acquiring an additional 146 shares during the last quarter. Moody National Bank Trust Division boosted its position in CVS Health by 0.7% during the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after acquiring an additional 150 shares during the last quarter. Landmark Financial Advisors LLC grew its stake in CVS Health by 3.8% in the 4th quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock worth $329,000 after acquiring an additional 153 shares during the period. Garland Capital Management Inc. lifted its stake in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after purchasing an additional 160 shares during the period. Finally, Sepio Capital LP grew its position in shares of CVS Health by 1.7% in the fourth quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock valued at $782,000 after purchasing an additional 163 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

NYSE:CVS opened at $57.98 on Monday. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The business’s 50-day moving average price is $58.28 and its 200 day moving average price is $63.00. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The firm has a market cap of $72.79 billion, a P/E ratio of 10.19, a PEG ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same quarter last year, the company posted $2.21 EPS. CVS Health’s revenue for the quarter was up 2.6% on a year-over-year basis. As a group, sell-side analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio is 46.75%.

Analysts Set New Price Targets

CVS has been the topic of a number of research analyst reports. Barclays decreased their price target on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Wells Fargo & Company upped their price target on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Baird R W upgraded CVS Health to a “hold” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft lowered their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, September 10th. Eleven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.